Search results for "" 2268 results found
Sort By
By Date
By Relevance
-
Team
Olivia Oxton
I specialise in brand protection and enforcement, with a particular focus on trade marks. I enjoy working closely with clients and colleagues to strategically and creatively develop, protect and grow brands on an international scale. My practice involves advising a broad spectrum of clients, ranging from individuals and start-ups to… -
Team
Sophie Rann
I joined the trade mark team at D Young & Co in January 2022 having completed a law degree at the University of Nottingham. I find it very rewarding to see our clients' trade marks in use, whether that be for their products or brands in supermarkets or on TV.… -
IP Cases & Articles
Salvaging design protection from a PCT patent application
When it comes to protecting an idea in many territories around the world with patent protection, one of the best ways to initiate that process is to pursue an international PCT patent application. Doing so allows a deferment of the decision regarding where to pursue such patent protection, in many… -
Newsletter
Patent Newsletter No.90
-
IP Cases & Articles
T 1123/16 & T 2963/19: clinical trial protocols as closest prior art
Two recent decisions from the EPO Board of Appeal considered whether clinical trial protocols provide the skilled person with a reasonable expectation of success. The decisions add to the growing body of case law in this area. -
IP Cases & Articles
Issues concerning the grant of machine learning patents at the EPO
How much information should you include in your machine learning (ML) patent application to give it the best chance of being granted by the European Patent Office (EPO)? -
IP Cases & Articles
UK R&D tax credit landscape - upcoming proposed changes
In what is clearly good news for many, the UK Government has drafted a number of pleasing changes to the UK research and development tax credit landscape. These changes follow from the recent consultation which the UK Government held on this point, which we previously reported on. -
IP Cases & Articles
Sandoz v Teva UK: revocation of UK formulation patents for blockbuster drug, Apixaban
Eliquis®, the Bristol Myers Squibb (BMS) and Pfizer apixaban product, was recently ranked in the top five pharmaceutical products sold worldwide, with a significant increase in demand resulting from the Covid-19 pandemic. Enforceability of BMS and Pfizer’s patent portfolio will clearly be critical to the ongoing success of this blockbuster… -
IP Cases & Articles
T 3000/19: how do you solve a problem like video evidence?
A European Patent Office (EPO) Board of Appeal was recently asked to consider a case where an online video was cited against a patent application, with just one problem: the video was no longer available. In T 3000/19, the Board of Appeal addressed what should be done when electronic evidence… -
IP Cases & Articles
Artificial intelligence originating inventions: can an AI system be designated as inventor?
Artificial Intelligence (AI) is a rapidly developing area of technology. AI systems are now capable of driving autonomous cars, performing translation of text, and assisting in healthcare and construction. AI systems are even capable of beating humans in games such as chess – an achievement which was originally considered out…
Page 72 of 227
Previous Next